Tandem Diabetes terminates CCO Mark Novara without cause; last day May 18

TANDEM DIABETES CARE INC

Mark Novara, EVP & Chief Commercial Officer, notified of termination without cause on May 11, 2026.
His last day of employment is scheduled to be May 18, 2026.
Company states its strategy and 2026 goals remain unchanged.
No successor has been announced as of the filing date.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Mark Novara

Executive Vice President and Chief Commercial Officer

TNDM · TANDEM DIABETES CARE INC

Effective: 2026-05-18
Filed: May 15, 2026, 7:59 AM ET

On May 11, 2026, Mark Novara, the Executive Vice President and Chief Commercial Officer of Tandem Diabetes Care, Inc. (the “Company”), was notified that his employment with the Company is being terminated without cause.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Mark Novara was terminated as Executive Vice President and Chief Commercial Officer at TANDEM DIABETES CARE INC.

Action: terminated
Role: Executive Vice President and Chief Commercial Officer

Exact text from the filing

On May 11, 2026, Mark Novara, the Executive Vice President and Chief Commercial Officer of Tandem Diabetes Care, Inc. (the “Company”), was notified that his employment with the Company is being terminated without cause.

View on SEC.gov

TANDEM DIABETES CARE INC filing history →

Source: SEC EDGAR

accession 0001438133-26-000052

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.